# Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)

> **NCT02043002** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 67 (actual)

## Conditions studied

- Non-small Cell Lung Cancer Patients

## Interventions

- **PROCEDURE:** 18F-FDG-PET scan

## Key facts

- **NCT ID:** NCT02043002
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-08
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043002, "Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02043002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*